Amgen Inc (AMGN · NASDAQ)
AMGN · MARKET VIEW
Market view · as of Jul 27, 2026
Revenue (TTM)
$37.22B
+5.8% YoY
Gross margin
71.4%
EPS (latest q)
$5.15
vs $4.77 est · beat
52-wk position
92.4%
-2.4% vs 52w high · +6.6% 1mo
Price (last ~year)
Amgen Inc. (AMGN) reported first-quarter 2026 revenue of $8.62 billion, marking four consecutive quarters of earnings beats. The biopharmaceutical company, which maintains a market capitalization of $202.95 billion, recorded trailing twelve-month revenue of $37.22 billion and an operating margin of 33.8%. Shares are currently priced at $376.04, reflecting an 11.6% gain over the last three months, while the firm carries $57.32 billion in total debt with a debt-to-EBITDA ratio of 3.4x.
Valuation
- Market cap
- $202.95B
- P/E
- 26.19
- PEG
- 2.061
- P/B
- 22.08
- P/S
- 5.45
- EV/EBITDA
- 14.89
- Beta
- 0.403
- Analyst target
- $356.69
Quality & returns
- Gross margin
- 71.4%
- Operating margin
- 33.8%
- Profit margin
- 21.0%
- ROE
- 101.3%
- ROA
- 8.3%
Price movement
- Last
- $376.04
- 1-month
- +6.6%
- 3-month
- +11.6%
- RSI (14)
- 60
- vs SMA200
- +11.2%
- 52-wk position
- 92.4% -2.4% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $8.62B | $2.67B | $1.82B | $3.86B |
| 2025-12-31 | $9.90B | $3.94B | $1.33B | $3.30B |
| 2025-09-30 | $9.56B | $2.53B | $3.22B | $5.91B |
| 2025-06-30 | $9.17B | $2.64B | $1.43B | $3.62B |
Recent news
- Somewhat-Bullish Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates · 2026-07-26
- Somewhat-Bullish Uniqure NV (QURE) Earnings Forecast: Future EPS & Revenue Growth Estimates · 2026-07-26
- Neutral Amgen (AMGN) Beat Revenue Forecasts, Is The Stock Overvalued? · 2026-07-26
- Somewhat-Bullish Amgen Inc. $AMGN Shares Purchased by OMERS ADMINISTRATION Corp · 2026-07-26
- Neutral Amgen Inc. $AMGN Shares Sold by Healthcare of Ontario Pension Plan Trust Fund · 2026-07-26
- Neutral HUTCHMED (China) Ltd (HCM) Earnings Forecast: Future EPS & Revenue Growth Estimates · 2026-07-26
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)